Medtech InsightHigh bleeding risk patients treated with Medtronic PLC ’s Resolute Onyx zotarolimus-eluting coronary stent and one month of dual-antiplatelet therapy in the Onyx ONE Clear trial showed low rates of
Medtech InsightResults of the IDEAL LM trial showed patients with left main coronary artery disease treated with Boston Scientific Corp. 's Synergy everolimus-eluting platinum-chromium stent with a biodegradable
Medtech InsightThis year's annual Trancatheter Cardiovascular Therapeutics conference, the largest meeting for interventional cardiologists, will continue the ongoing discussion on controversies around drug-coated b
Medtech Insight[ Editor's note : Complete historical information on important medical device trial announcements is available from Informa’s MedDeviceTracker . Click here to request a demonstration. For an archive